Qingdao Vland Biotech INC

Short Term Long Term Short Term Comparison Long Term Comparison
  • 603739
  • 1d-6.47%
  • 1w-8.39%
  • 1m-6.91%
  • 1y-29.60%
ATH
  • ATH Price$58.91
  • ATH Date2019-01-28
  • % since ATH-83.31%
  • % to ATH499.33%
ATL
  • ATL Price$8.17
  • ATL Date2024-02-07
  • % from ATL20.32%
  • Last Low Price$8.17
  • Last Low Date2024-02-07
  • % From Last Low20.32%
IPO
  • IPO Price$40.25
  • % Current ROI USD-75.58%
  • ATH Price$58.91
  • % ROI ATH 72,110.65%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="603739"]

Key Data [addtoany]

Current price $9.83
Sector Healthcare
Industry Biotechnology
Today's High/Low $10.55/$9.69
Volume 1,813,300.00
Previous Close $10.51
52 Week High/Low $18.26/$7.7
Market Cap 2,659,334,656.00
P/E Ratio 38.9259
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.0095
$9.83
[addtoany]

Qingdao Vland Biotech INC. engages in the research and development of enzymes, probiotics, and animal vaccines and health products.
It offers animal feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics.
The company also offers animal vaccines and biological products, such as live and inactivated poultry, and swine vaccines, as well as antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens.
It serves agriculture, animal husbandry, textile, paper making, household cleaning and detergents, food, biofuel, environmental protection, and other industries.
The company was founded in 2005 and is headquartered in Qingdao, China. Qingdao Vland Biotech INC. is a subsidiary of Qingdao Kangdien Industrial Co., Ltd.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity